EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Anti-Cancer Activity, and Molecular Docking of New Co(II), Ni(II) and Cu(II)Complexes with an Imidazole-Azo Ligand

Ali Abdulhussein, Israa N.Witwit

Applied Chemical Engineering · 25.06.2026

DOI: 10.59429/ace.v9i2.5986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Chemical Engineering, online erschienen am 25.06.2026. Verfasst von Ali Abdulhussein und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The development of metal-based therapeutics represents a significant advancement in medicinal inorganic chemistry. Here, the strategic synthesis and comprehensive characterization of a new imidazole-azo ligand, (E)-4-methyl-2-((4-phenoxyphenyl)diazinyl)imidazole (MPDI), are presented. Divalent transition metal complexes with Co(II), Ni(II), and Cu(II) were also investigated.

Methods

The compounds were characterized using 1HNMR, mass spectrometry, UV-Vis spectroscopy, and CHN analysis. Structural investigations, including molar conductivity and magnetic susceptibility measurements, confirmed a non-electrolytic octahedral geometry for all complexes. Scanning electron microscopy (SEM) revealed a significant morphological transformation from bulk microcrystalline ligands 5–20 μm to nano-sized, interconnected porous networks 100–250 nm in the Ni(II) complexes, attributed to the metal-template effect.

Results

Cytotoxicity was assessed against the MCF-7 breast cancer cell line using the MTT assay. Coordination resulted in a marked synergistic enhancement of bio-potency; the free ligand exhibited an IC50 of 1211.53 mu g/mL, while the Cu(II) complex demonstrated a 26.5-fold increase in efficacy with an IC50 of 45.70 \mu g/mL. Molecular docking simulations with the 5T92 protein (Estrogen Receptor Alpha) supported these results, revealing high binding affinities ranging from -15.26 to -17.24 kcal/mol. The Ni(II) complex showed the strongest theoretical affinity, stabilized by a unique π-cation interaction with ARG394.

Zitieren

APA

Abdulhussein, A., & N.Witwit, I. (2026). Synthesis, Anti-Cancer Activity, and Molecular Docking of New Co(II), Ni(II) and Cu(II)Complexes with an Imidazole-Azo Ligand. Applied Chemical Engineering. https://doi.org/10.59429/ace.v9i2.5986

Vancouver

Abdulhussein A, N.Witwit I. Synthesis, Anti-Cancer Activity, and Molecular Docking of New Co(II), Ni(II) and Cu(II)Complexes with an Imidazole-Azo Ligand. Applied Chemical Engineering. 2026. doi:10.59429/ace.v9i2.5986

BibTeX
@article{Abdulhussein2026,
  author = {Abdulhussein, Ali and N.Witwit, Israa},
  title = {Synthesis, Anti-Cancer Activity, and Molecular Docking of New Co(II), Ni(II) and Cu(II)Complexes with an Imidazole-Azo Ligand},
  journal = {Applied Chemical Engineering},
  year = {2026},
  doi = {10.59429/ace.v9i2.5986}
}
Kostenlos starten →